View Single Post
Old 10-11-2016, 01:30 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,960
Targeting estrogen receptor improves progression-free survival in advanced breast can

Fulvestrant significantly increases progression-free survival in women with hormone-receptor-positive advanced breast cancer, particularly those with less aggressive lower-volume disease...

More...
News is offline   Reply With Quote